FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use
Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CPM-CCT2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CPM-CCT2
FusionPDB ID: 18986
FusionGDB2.0 ID: 18986
HgeneTgene
Gene symbol

CPM

CCT2

Gene ID

1368

10576

Gene namecarboxypeptidase Mchaperonin containing TCP1 subunit 2
Synonyms-99D8.1|CCT-beta|CCTB|HEL-S-100n|PRO1633|TCP-1-beta
Cytomap

12q15

12q15

Type of geneprotein-codingprotein-coding
Descriptioncarboxypeptidase Mrenal carboxypeptidaseurinary carboxypeptidase BT-complex protein 1 subunit betaT-complex protein 1, beta subunitchaperonin containing TCP1, subunit 2 (beta)chaperonin containing t-complex polypeptide 1, beta subunitchaperonin containing t-complex polypeptide 1, subunit 2epididymis secretory sperm
Modification date2020031320200313
UniProtAcc

P14384

Main function of 5'-partner protein: FUNCTION: Specifically removes C-terminal basic residues (Arg or Lys) from peptides and proteins. It is believed to play important roles in the control of peptide hormone and growth factor activity at the cell surface, and in the membrane-localized degradation of extracellular proteins. {ECO:0000269|PubMed:12457462}.

P78371

Main function of 5'-partner protein: FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis (PubMed:25467444). The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance (PubMed:25467444). As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (PubMed:20080638). The TRiC complex plays a role in the folding of actin and tubulin (Probable). {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444, ECO:0000305}.
Ensembl transtripts involved in fusion geneENST idsENST00000338356, ENST00000546373, 
ENST00000551568, ENST00000549691, 
ENST00000299300, ENST00000543146, 
ENST00000544368, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score15 X 8 X 7=84014 X 13 X 9=1638
# samples 1716
** MAII scorelog2(17/840*10)=-2.30485458152842
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(16/1638*10)=-3.35579154675365
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: CPM [Title/Abstract] AND CCT2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CPM [Title/Abstract] AND CCT2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CCT2(69979304)-CPM(69252851), # samples:3
CPM(69279572)-CCT2(69986756), # samples:2
Anticipated loss of major functional domain due to fusion event.CCT2-CPM seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
CCT2-CPM seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
CCT2-CPM seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
CPM-CCT2 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
CPM-CCT2 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
CPM-CCT2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:69979304/chr12:69252851)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CPM (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across CCT2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)
ENST00000338356CPMchr1269279572-ENST00000299300CCT2chr1269986756+1408305471162371
ENST00000338356CPMchr1269279572-ENST00000544368CCT2chr1269986756+1221305471147366
ENST00000338356CPMchr1269279572-ENST00000543146CCT2chr1269986756+1403305471162371

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000338356ENST00000299300CPMchr1269279572-CCT2chr1269986756+0.0004670990.99953294
ENST00000338356ENST00000544368CPMchr1269279572-CCT2chr1269986756+0.000447350.99955267
ENST00000338356ENST00000543146CPMchr1269279572-CCT2chr1269986756+0.0004782770.99952173

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CPM-CCT2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
CPMchr1269279572CCT2chr126998675630586PEFKYVANMHGDEIFGSRVRVDSTAK

Top

Potential FusionNeoAntigen Information of CPM-CCT2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CPM-CCT2_69279572_69986756.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CPM-CCT2chr1269279572chr1269986756305HLA-B18:01DEIFGSRV0.99620.91451119
CPM-CCT2chr1269279572chr1269986756305HLA-A66:01EIFGSRVRV0.99840.60441221
CPM-CCT2chr1269279572chr1269986756305HLA-A26:03EIFGSRVRV0.99270.62791221
CPM-CCT2chr1269279572chr1269986756305HLA-A26:02EIFGSRVRV0.97230.51931221
CPM-CCT2chr1269279572chr1269986756305HLA-A26:14EIFGSRVRV0.95130.6051221
CPM-CCT2chr1269279572chr1269986756305HLA-A26:15EIFGSRVRV0.95130.6051221
CPM-CCT2chr1269279572chr1269986756305HLA-A26:01EIFGSRVRV0.95130.6051221
CPM-CCT2chr1269279572chr1269986756305HLA-C08:04VANMHGDEI0.64730.9448514
CPM-CCT2chr1269279572chr1269986756305HLA-C08:13VANMHGDEI0.64730.9448514
CPM-CCT2chr1269279572chr1269986756305HLA-C08:03VANMHGDEI0.16520.9736514
CPM-CCT2chr1269279572chr1269986756305HLA-B18:05DEIFGSRV0.99620.91451119
CPM-CCT2chr1269279572chr1269986756305HLA-B18:06DEIFGSRV0.99610.92121119
CPM-CCT2chr1269279572chr1269986756305HLA-B18:03DEIFGSRV0.9920.90921119
CPM-CCT2chr1269279572chr1269986756305HLA-A68:02EIFGSRVRV0.99780.75791221
CPM-CCT2chr1269279572chr1269986756305HLA-A69:01EIFGSRVRV0.9930.76561221
CPM-CCT2chr1269279572chr1269986756305HLA-A25:01EIFGSRVRV0.98070.92181221
CPM-CCT2chr1269279572chr1269986756305HLA-B18:06DEIFGSRVR0.93430.95381120
CPM-CCT2chr1269279572chr1269986756305HLA-C03:06VANMHGDEI0.80260.9894514
CPM-CCT2chr1269279572chr1269986756305HLA-C08:01VANMHGDEI0.16520.9736514

Top

Potential FusionNeoAntigen Information of CPM-CCT2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CPM-CCT2_69279572_69986756.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CPM-CCT2chr1269279572chr1269986756305DRB1-0401PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0403PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0407PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0415PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0419PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0424PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0427PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0431PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0433PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0434PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0435PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0436PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0438PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0439PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0441PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0443PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0446PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0447PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0449PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0450PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0451PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0452PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0453PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0454PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0458PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0459PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0460PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0461PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0462PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0463PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0464PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0465PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0469PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0471PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0472PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0474PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0475PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0476PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0478PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0480PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0482PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0485PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0486PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0488PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0815PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-0830PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1130PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1367PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1446PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1511PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1515PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1527PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1531PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1534PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1601PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1602PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1603PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1604PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1605PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1607PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1608PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1609PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1610PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1611PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1612PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1614PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB1-1616PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB5-0102PEFKYVANMHGDEIF015
CPM-CCT2chr1269279572chr1269986756305DRB5-0108NPEFKYVANMHGDEIF015

Top

Fusion breakpoint peptide structures of CPM-CCT2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
455ANMHGDEIFGSRVRCPMCCT2chr1269279572chr1269986756305

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CPM-CCT2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN455ANMHGDEIFGSRVR-7.9962-8.1096
HLA-B14:023BVN455ANMHGDEIFGSRVR-5.70842-6.74372
HLA-B52:013W39455ANMHGDEIFGSRVR-6.83737-6.95077
HLA-B52:013W39455ANMHGDEIFGSRVR-4.4836-5.5189
HLA-A11:014UQ2455ANMHGDEIFGSRVR-10.0067-10.1201
HLA-A11:014UQ2455ANMHGDEIFGSRVR-9.03915-10.0745
HLA-A24:025HGA455ANMHGDEIFGSRVR-6.56204-6.67544
HLA-A24:025HGA455ANMHGDEIFGSRVR-5.42271-6.45801
HLA-B44:053DX8455ANMHGDEIFGSRVR-7.85648-8.89178
HLA-B44:053DX8455ANMHGDEIFGSRVR-5.3978-5.5112
HLA-A02:016TDR455ANMHGDEIFGSRVR-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of CPM-CCT2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
CPM-CCT2chr1269279572chr12699867561119DEIFGSRVGATGAGATATTTGGTTCCCGGGTA
CPM-CCT2chr1269279572chr12699867561120DEIFGSRVRGATGAGATATTTGGTTCCCGGGTAAGA
CPM-CCT2chr1269279572chr12699867561221EIFGSRVRVGAGATATTTGGTTCCCGGGTAAGAGTT
CPM-CCT2chr1269279572chr1269986756514VANMHGDEIGTGGCAAATATGCATGGAGATGAGATA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
CPM-CCT2chr1269279572chr1269986756015PEFKYVANMHGDEIFCCAGAGTTCAAATACGTGGCAAATATGCATGGAGATGAGATATTT

Top

Information of the samples that have these potential fusion neoantigens of CPM-CCT2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCCPM-CCT2chr1269279572ENST00000338356chr1269986756ENST00000299300TCGA-DX-A1KU-01A

Top

Potential target of CAR-T therapy development for CPM-CCT2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to CPM-CCT2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CPM-CCT2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource